| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 5,419 | 5,469 | 20,904 | 6,828 | | Cost of Revenue | (26,796) | 27,757 |
-
| (1,782) | | | Gross Profit | 32,215 | (22,288) | 20,904 | 8,610 | | | Operating Expenses | | Research Development | 38,230 | (14,635) | 15,460 | 16,929 | | Selling General and Administrative | 5,844 | 7,095 | 6,819 | 6,304 | | Non Recurring | 98 |
-
|
-
|
-
| | Others | 1,207 | 1,223 | 1,203 | 1,182 | | | | Total Operating Expenses | 45,379 |
-
|
-
|
-
| | | | Operating Income or Loss | (13,164) | (15,971) | (2,578) | (15,805) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 150 | 800 | 790 | 1,207 | | Earnings Before Interest And Taxes | (13,014) | (15,171) | (1,788) | (14,598) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (13,014) | (15,171) | (1,788) | (14,598) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,014) | (15,171) | (1,788) | (14,598) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,014) | (15,171) | (1,788) | (14,598) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,014) | ($15,171) | ($1,788) | ($14,598) |
|
0.26% Nasdaq 0.00%
Income Statement
